![Stephen Uden](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Uden
Gründer bei
RALLYBIO CORPORATION
Vermögen: 2 Mio $ am 31.08.2026
Profil
Dr. Stephen Uden, MD, is a President, Chief Executive Officer & Director at Rallybio Corp.
and a President, Chief Executive Officer & Director at Rallybio LLC.
He is on the Board of Directors at Rallybio Corp.
and Rallybio LLC.
Dr. Uden was previously employed as a Senior Vice President-Research by Alexion Pharmaceuticals, Inc. and a Head-Research & Development by Neurogen Corp.
He received his undergraduate degree from the University of London.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
RALLYBIO CORPORATION 1.73% | 19.12.2025 | 91’920 ( 1.73% ) | 2 Mio $ | 31.08.2026 |
Aktive Positionen von Stephen Uden
| Unternehmen | Position | Beginn |
|---|---|---|
| RALLYBIO CORPORATION | Gründer | 01.01.2018 |
Rallybio LLC
 Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotech company that delivers groundbreaking therapies | Gründer | 01.01.2018 |
Ehemalige bekannte Positionen von Stephen Uden
| Unternehmen | Position | Ende |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.10.2017 |
Neurogen Corp.
 Neurogen Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Technik-/Wissenschafts-/F&E-Leiter | 14.09.2007 |
Ausbildung von Stephen Uden
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
68
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rallybio LLC
Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotech company that delivers groundbreaking therapies | Commercial Services |
Rallybio Corp.
 Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
